Core Scientific Stock Sinks After Q4 Revenue Miss and Accounting Restatement

Core Scientific's (CORZ) shares drop after Q4 2025 results show lower revenue than expected, plus a restatement of past financials due to overstated assets—no impact on key metrics like sales or cash flow.